HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiro Takahata Selected Research

Punctures

1/2021Optimal hemostasis duration for percutaneous coronary intervention via the snuffbox approach: A prospective, multi-center, observational study (HEMOBOX).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiro Takahata Research Topics

Disease

5Infections
02/2014 - 08/2002
4Myocardial Infarction
01/2023 - 01/2020
3Infarction (Infarctions)
03/2024 - 12/2021
3Acute Coronary Syndrome
03/2024 - 01/2021
3Death (Near-Death Experience)
01/2023 - 11/2018
3Rupture
01/2023 - 01/2020
3Communicable Diseases (Infectious Diseases)
08/2012 - 09/2011
2Coronary Stenosis (Coronary Artery Stenosis)
01/2023 - 11/2018
2Heart Failure
01/2023 - 09/2021
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2023 - 11/2018
2ST Elevation Myocardial Infarction
12/2021 - 12/2020
2Urethritis
06/2008 - 12/2002
1No-Reflow Phenomenon
03/2024
1Aortic Valve Stenosis (Aortic Stenosis)
10/2022
1Pathologic Constriction (Stenosis)
02/2022
1Thrombosis (Thrombus)
01/2022
1Heart Arrest (Cardiac Arrest)
09/2021
1Unstable Angina
09/2021
1Cardiac Arrhythmias (Arrythmia)
09/2021
1Atrial Fibrillation
09/2021
1Bradycardia
09/2021
1Pulmonary Embolism
09/2021
1Ventricular Tachycardia
09/2021
1Stroke (Strokes)
09/2021
1Atherosclerotic Plaque (Atheroma)
02/2021
1AIDS-Related Complex (ARC)
02/2021
1Hypesthesia (Numbness)
01/2021
1Hematoma
01/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2018
1Pneumococcal Pneumonia
02/2014
1Pneumonia (Pneumonitis)
02/2014
1Human Influenza (Influenza)
02/2014
1Calculi (Calculus)
08/2002
1Body Weight (Weight, Body)
06/2002
1Meningitis
06/2002
1Sepsis (Septicemia)
02/2002

Drug/Important Bio-Agent (IBA)

5LipidsIBA
03/2024 - 02/2021
4garenoxacinIBA
02/2014 - 09/2011
3QuinolonesIBA
08/2012 - 07/2005
2FluoroquinolonesIBA
02/2014 - 07/2005
2Therapeutic UsesIBA
02/2014 - 08/2002
2Cefixime (Suprax)FDA Link
06/2008 - 12/2002
2Anti-Bacterial Agents (Antibiotics)IBA
07/2005 - 08/2002
1omega-Chloroacetophenone (Mace)IBA
01/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2023
1EverolimusFDA Link
01/2022
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
06/2008
1Carbapenems (Carbapenem Antibiotics)IBA
07/2005
1panipenemIBA
07/2005
1ImipenemFDA Link
07/2005
1Meropenem (Merrem)FDA LinkGeneric
07/2005
1Ciprofloxacin (Cipro)FDA LinkGeneric
07/2005
1pazufloxacinIBA
07/2005
1Mesylates (Mesylate)IBA
08/2002
1beta-LactamsIBA
08/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2002
1Penicillins (Penicillin)FDA Link
06/2002
1T 3811MEIBA
06/2002
1AminoglycosidesIBA
02/2002

Therapy/Procedure

8Percutaneous Coronary Intervention
03/2024 - 11/2018
4Therapeutics
01/2023 - 02/2002
3Stents
02/2022 - 01/2021
1Transcatheter Aortic Valve Replacement
10/2022
1Emergency Treatment
09/2021
1Punctures
01/2021
1Drug-Eluting Stents
11/2018
1Injections
07/2005
1Intravenous Administration
08/2002